Abstract:Objective: The tumour microenvironment is one of the major factors to drive the carcinogenesis of pancreatic cancer. Immunocytes and stromal cells represent major components of tumor microenvironment in PDAC. Different types of tumor-infiltrating immunocytes changes in proportion and function contribute to pancreatic cancer initiation and progression. While the underlying mechanism of how tumor microenvironment determined the prognosis of pancreatic cancer and the regulatory mechanism of the infiltration of immunocytes in the tumor environment of PDAC are both poor understood.Methods: Transcriptome datasets from the TCGA database was used to determine stromal and immune scores by using the ESTIMATE scoring. An mRNA-based prognostic signature was built for the training cohort via the LASSO Cox regression model.Moreover, the signature was verified using the validation cohort. The Kaplan-Meier curves with the log-rank analysis were used to identify the survival differences. Western blot and RT-qPCR were carried out to analyze the expression of specific proteins and mRNAs. IHC was performed to examine the protein levels of FOXO1, CA9, CXCL9 and GIMAP7 in the tissue microarray of pancreatic cancer.Results: The transcriptome and clinical data of 182 PAAD program cases were downloaded from the TCGA database. Three hundred thirty-three differentially expressed genes (DEGs) between high and low stromal groups and 314 DEGs between high and low immune score groups were identified by applying ESTIMATE score. Based on the 203 genes simultaneously differentially expressed in two score-related comparisons, we established an 8-mRNA signature to evaluate the prognosis of pancreatic cancer patients. The Kaplan-Meier curves showed a significantly worse survival for those patients with high-risk scores in both training and validation groups. The risk score was an independent prognostic factor and had a high predictive value for the prognosis of patients with pancreatic cancer. By searching the TCGA database, we showed that CA9, CXCL9, and GIMAP7 from 8 mRNA signature were associated with infiltration level of immunocytes, and these three proteins regulate FOXO1 expression in pancreatic cancer. Conclusions: Unlike traditional methods of screening for differential genes through cancer and healthy tissues, we constructed a novel 8-mRNA signature to predict the prognosis of pancreatic cancer patients by applying ESTIMATE scoring to RNA-seq-based transcriptome. Most importantly, we identified CA9, CXCL9 and GIMAP7 from above eight genes regulated the immunocytes infiltration via FOXO1 in pancreatic cancer. Thus, CA9, CXCL9, and GIMAP7 might be the ideal targets of immune therapy of pancreatic cancer.Funding: National Natural Science Foundation of China (Grant No. 81702374 (X.J.)).Declaration of Interest: There were no potential conflicts of interest are disclosed.Ethical Approval: Not applicable.

Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO

Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer

Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network

Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer

Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer

Identification of a 4-Mrna Metastasis-Related Prognostic Signature for Patients with Breast Cancer.

Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma

A Robust 6-Mrna Signature for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma

Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment

Applying ESTIMATE Algorithm to Establish an 8-Mrna Signature Prognostic Prediction System and Identify Immunocytes Infiltration Related Genes in Pancreatic Cancer

Identification of a Two Metastasis-Related Prognostic Signature in the Process of Predicting the Survival of Laryngeal Squamous Cell Carcinoma.

Identification of metastasis-related long non-coding RNAs in lung cancer through a novel tumor mesenchymal score

A Novel Prognostic Signatures Based on Metastasis- and Immune-Related Gene Pairs for Colorectal Cancer.

Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer

Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model

A Risk Score Model for the Prediction of Osteosarcoma Metastasis

Identification of fibroblast-related genes based on single-cell and machine learning to predict the prognosis and endocrine metabolism of pancreatic cancer

Integrating High-Throughput Microrna and Mrna Expression Data to Identify Risk Mrna Signature for Pancreatic Cancer Prognosis

Development of Epithelial-Mesenchymal Transition-Related Lncrna Signature for Predicting Survival and Immune Microenvironment in Pancreatic Cancerwithexperiment Validation